Μετάβαση στο περιεχόμενο

ΕτικέταColon Cancer

Exact Sciences Shares Rocket as Pfizer Agrees to Co-Market Cologuard Colon Cancer Test

Madison, Wisconsin-based EXACT Sciences stocks climbed as much as 21 percent in premarket trading in response to a deal with Pfizer to co-market Exact’s Cologuard non-invasive colon cancer test. As part of the terms of the deal, the … Continue Reading Exact Sciences Shares Rocket as Pfizer Agrees to Co-Market Cologuard Colon Cancer Test